Table 1 Summary of clinicopathological features and follow up of patients with pancreatic cancer
From: Epigenetic silencing of AATK in acinar to ductal metaplasia in murine model of pancreatic cancer
Characteristics | Number (%) | AATK expression | P | |
|---|---|---|---|---|
Low | High | |||
Age | ||||
< 65 | 41 (49.4) | 32 (78.0) | 9 (22.0) | 0.055 |
> 65 | 42 (50.6) | 39 (92.9) | 3 (7.1) |  |
Sex | ||||
Male | 28 (33.7) | 23 (82.1) | 5 (17.9) | 0.530 |
Female | 55 (66.3) | 48 (87.3) | 7 (12.7) | Â |
Tumor location | ||||
Head | 52 (62.7) | 43 (82.7) | 9 (17.3) | 0.142 |
Neck | 6 (7.2) | 6 (100.0) | 0 (0.0) | Â |
Body | 4 (4.8) | 2 (50.0) | 2 (50.0) | Â |
Tail | 6 (7.2) | 6 (100.0) | 0 (0.0) | Â |
Uncinate | 10 (12.0) | 10 (100.0) | 0 (0.0) | Â |
Others | 5 (6.0) | 4 (80.0) | 1 (20.0) | Â |
Tumor size, cm | ||||
≤ 3 | 47 (56.6) | 40 (85.1) | 7 (14.9) | 0.897 |
> 3 | 36 (43.4) | 31 (86.1) | 5 (13.9) |  |
Tumor grade | ||||
Poorly differentiated | 17 (20.5) | 16 (94.1) | 1 (5.9) | 0.466 |
Moderately differentiated | 46 (55.4) | 39 (84.8) | 7 (15.2) | Â |
Well differentiated | 20 (24.1) | 16 (80.0) | 4 (20.0) | Â |
Stage | ||||
I | 9 (10.8) | 7 (77.8) | 2 (22.2) | 0.733 |
II | 69 (83.1) | 59 (85.5) | 10 (14.5) | Â |
III | 4 (4.8) | 4 (5.6) | 0 (0.0) | Â |
IV | 1 (1.2) | 1 (100.0) | 0 (0.0) | Â |
Recurrence status | ||||
Absent | 22 (26.5) | 18 (81.8) | 4 (18.2) | 0.562 |
Present | 61 (73.5) | 53 (86.9) | 8 (13.1) | Â |
Metastatic status | ||||
Absent | 39 (47.0) | 32 (82.1) | 7 (17.9) | 0.395 |
Present | 44 (53.0) | 39 (88.6) | 5 (11.4) | Â |
CA199 | ||||
< 37U/ml | 14 (16.9) | 12 (85.7) | 2 (14.3) | 0.987 |
> 37U/ml | 63 (75.9) | 54 (85.7) | 9 (14.3) |  |